ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,617,741 | +10.1% | 501,864 | +24.7% | 0.00% | 0.0% |
| Q2 2023 | $12,373,030 | -12.0% | 402,547 | +3.2% | 0.00% | -20.0% |
| Q1 2023 | $14,052,357 | +109273.9% | 389,959 | +20.0% | 0.01% | +25.0% |
| Q4 2022 | $12,848 | -99.9% | 325,077 | -3.1% | 0.00% | -20.0% |
| Q3 2022 | $13,479,000 | +9.4% | 335,439 | +14.5% | 0.01% | +25.0% |
| Q2 2022 | $12,316,000 | +10.9% | 292,960 | +2.8% | 0.00% | +33.3% |
| Q1 2022 | $11,102,000 | +21.0% | 284,941 | +23.8% | 0.00% | 0.0% |
| Q4 2021 | $9,174,000 | +58.1% | 230,201 | +43.4% | 0.00% | +50.0% |
| Q3 2021 | $5,803,000 | +1447.5% | 160,515 | +1655.0% | 0.00% | – |
| Q2 2021 | $375,000 | -9.2% | 9,146 | -3.1% | 0.00% | – |
| Q1 2021 | $413,000 | – | 9,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |